Document is current
Any future updates will be listed below
-
Authors
Streeter, Samuel S. https://orcid.org/0000-0001-8267-3556
Hebert, Kendra A.
Bateman, Logan M.
Ray, Gabrielle S.
Dean, Ryan E.
Geffken, Kurt T.
Resnick, Corey T.
Austin, Daniel C.
Bell, John-Erik
Sparks, Michael B.
Gibbs, Summer L.
Samkoe, Kimberley S.
Gitajn, I. Leah
Elliott, Jonathan Thomas
Henderson, Eric R.
-
Funding
Funding for this research was provided by:
Hitchcock Foundation (250-4141)
National Institute of Biomedical Imaging and Bioengineering (K23EB026507)
National Institute of Neurological Disorders and Stroke (R01NS116994)
National Cancer Institute (F31CA257340)
- License Information
-
More Information
Article History
Received: 18 July 2022
Revised: 1 November 2022
Accepted: 16 November 2022
First Online: 29 November 2022
Declarations
:
: S. Streeter is a part-time employee of QUEL Imaging LLC, a Small Business Innovation Research-funded start-up that focuses on the commercialization of optical targets for fluorescence guided surgical systems. S. Gibbs is a co-founder and stockholder of Trace Biosciences, a start-up company focused on the development and clinical translation of nerve-specific probes for FGS. S. Gibbs also has three patents pending related to this work (US No. 62/711,465, US No. 62/729,932, and US No. 62/956,614). E. Henderson is an educational consultant for Stryker Orthopaedics. All other authors declare no competing interests.
